Count | |
| 2 | |
| 3 | |
| 1 | |
| 5 | |
| 1 | |
| 7 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Immunoglobulin M/adverse effects/immunology/*therapeutic use | 1 |
| 1 | |
| 1 | |
| 1 | |
Immunoglobulin G/administration & dosage/adverse effects/*therapeutic use | 1 |
Immunoglobulin G/administration & dosage/adverse effects/blood | 1 |
Immunoglobulin Fragments/administration & dosage/*adverse effects | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Receptors, Polymeric Immunoglobulin/*biosynthesis/drug effects | 1 |
Receptors, Polymeric Immunoglobulin/*drug effects/metabolism | 1 |
Receptors, Polymeric Immunoglobulin/biosynthesis/drug effects/*genetics | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 12 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |